Specific Targeting of Breast Cancer Cells with Antibodies Conjugated Gold Nanoparticles

Title:Specific Targeting of Breast Cancer Cells with Antibodies Conjugated Gold Nanoparticles

Volume: 8 Issue: 3

Author(s): Zahrah Alhalili, Joe Shapter*, Daniela Figueroa and Barbara Sanderson

Affiliation:

• Flinders Centre for NanoScale Science and Technology, School of Chemical and Physical Sciences, Flinders University, Adelaide, SA 5001,Australia

Keywords: Gold nanoparticles, paclitaxel, EpCAM, TARP, antibodies, cytotoxicity, drug delivery.

Abstract: Background and Objective: Gold nanoparticles (AuNP) conjugated with either EpCAM or TARP antibodies and an anticancer agent, paclitaxel (PTX), for tumour targeting and therapy were synthesised using a simple chemistry.

Methods: The AuNP surface was functionalised using a two-step modification approach. The conjugates were characterised using Transmission Electron Microscopy (TEM) and infrared spectroscopy.

Results: The cytotoxicity assay of T47D cells treated with only antibodies conjugated to the gold nanoparticles did not show any cytotoxicity to the cells, which indicates these nanoconjugates are suitable for intracellular delivery of anticancer drugs.

Conclusion: When using AuNPs with antibodies and the cancer chemotherapy agent PTX attached simultaneously to the functionalised AuNPs, the reduction of cell viability was significantly higher compared to PTX-thiol-AuNPs conjugate system where no antibodies were used.

Cite this article as:

Alhalili Zahrah, Shapter Joe*, Figueroa Daniela and Sanderson Barbara, Specific Targeting of Breast Cancer Cells with Antibodies Conjugated Gold Nanoparticles, Drug Delivery Letters 2018; 8 (3) . https://dx.doi.org/10.2174/2210303108666180913115509